AxoSim is a biotech company working to empower advancements in human neuroscience so that patients in need can get the care they deserve. Its NerveSim® and BrainSim® platforms are revolutionizing the way that biopharmaceutical companies develop neurological drugs. AxoSim delivers human data, faster. This reduces clinical failure and enables companies to develop effective drugs more quickly and at lower cost. AxoSim works with its clients to save millions of dollars and years of research and development time, fostering innovation and facilitating breakthroughs in the treatment of the world’s most devastating neurological diseases such as Alzheimer's, Parkinson's and Multiple Sclerosis.